Ultralife Q4 GAAP EPS $0.01 vs $0.17 YoY; sales $43.9M; backlog $102.2M

ULTRALIFE CORP

2025-Q1 EPS reported $0.02 revenue$50,746,000

Q4 sales $43.9M, down from $44.5M YoY; Battery & Energy +11.7%, Communications -55.1%.
GAAP EPS $0.01 ($0.2M net income) vs $0.17 ($2.9M) in Q4 2023; adjusted EPS also $0.01.
Operating income $1.5M including $1.1M one-time acquisition costs; adjusted EBITDA $3.9M.
Full-year sales $164.5M (+3.7%); GAAP EPS $0.38 vs $0.44; adjusted EBITDA $16.5M.
Backlog and high-confidence orders $102.2M at year-end 2024 vs $78.0M at Q3 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.